Challenging Cases: Navigating the New Consensus Guideline on Persistent Genital Arousal Disorder/Genito-Pelvic Dysesthesia
April 22, 2021 at 5:30 pm Pacific / 8:30 pm Eastern
In March 2021, ISSWSH announced the publication of our latest manuscript on the management of Persistent Genital Arousal/Genito-Pelvic Dysesthesia. PGAD is a terrible condition of unwanted, unremitting sensations of genital arousal that is associated with a significant, negative psychosocial impact, which may include emotional lability, catastrophization, and suicidal ideation. Despite being first reported in 2001, PGAD remains poorly understood.
Join us for an exciting presentation and discussion on the first consensus paper focusing exclusively on the epidemiology, pathophysiology, and nomenclature of PGAD that also gives a detailed algorithm on how to approach diagnosis and treatment.
Meet the Speakers
Dr. Goldstein has been involved with sexual dysfunction research since the late 1970's. He has authored about 350 peer reviewed publications and multiple chapters, and edited 6 textbooks in the field. His interests include penile microvascular bypass surgery, surgery for dyspareunia, sexual health management post cancer treatment, genital dysesthesia/persistent genital arousal disorder, physiologic investigation of sexual function in men and women, and diagnosis and treatment of sexual dysfunction in men and women. Dr. Goldstein is Director of Sexual Medicine at Alvarado Hospital, Clinical Professor of Surgery at University of California, San Diego and practices medicine at San Diego Sexual Medicine. He is also Editor-in-Chief of Sexual Medicine Reviews and past Editor of The Journal of Sexual Medicine. He is a Past President of the International Society for the Study of Women’s Sexual Health and the Sexual Medicine Society of North America. He holds a degree in engineering from Brown University and received his medical degree from McGill University. The World Association for Sexual Health awarded the Gold Medal to Dr. Goldstein in 2009 in recognition of his lifelong contributions to the field, in 2012 he received the International Society for the Study of Women’s Sexual Health Award for Distinguished Service in Women’s Sexual Health, in 2013 he received the Lifetime Achievement Award from the Sexual Medicine Society of North America, and in 2014 he received the ISSM Lifetime Achievement Award from the International Society for Sexual Medicine. He is happily married to his college sweetheart Sue, and together they have three children and five grandchildren.
Mrs. Goldstein is an AASECT Certified Sexuality Educator and an ACRP Certified Clinical Research Coordinator, as well as managing editor of Sexual Medicine Reviews. She works at San Diego Sexual Medicine to develop clinical research projects, write protocols and oversee clinical trials, as well as supervise educational programs and support trainees. Mrs. Goldstein’s passion is education and in addition to co-authoring When Sex Isn’t Good to provide education and empowerment to women with sexual dysfunction, she has served as Education Chair of ISSWSH and currently serves on the Global Development and Online Services Committees and Chairs the Industry Relations Committee for the International Society for Sexual Medicine. In addition, she develops programs for The Institute for Sexual Medicine, a charitable corporation dedicated to research and education in the field.

Dr. Kim is a Senior Investigator at the Institute for Sexual Medicine in San Diego, as well as an associate editor of Sexual Medicine Reviews. A member of the AUA, ISSM, ISSWSH, and SMSNA, Dr. Kim has been engaged in research on the physiology of sexual dysfunction since the mid-1980s. He has published and lectured extensively and has participated in the training of numerous students and fellows in sexual medicine. He was among the early investigators to describe the role of nitric oxide in penile erection and has consistently contributed to the field of sexual medicine with research in both male and female sexual function, being recognized with numerous research prizes from various sexual medicine societies. Dr. Kim was a member of the editorial board of The Journal of Sexual Medicine for the first decade of the journal through 2014. Previously, he has held positions as Assistant Director of the Laboratory for Sexual Medicine Research at the Boston University School of Medicine, Chief Scientific Officer of Alagin Research, a biotechnology company devoted to developing therapeutics and diagnostics in sexual medicine, and Interim Vice President of R&D at Sprout Pharmaceuticals, assisting in gaining regulatory approval for the first treatment for hypoactive sexual desire disorder in premenopausal women in both the US and Canada. Dr. Kim continues to serve as a consultant to other companies developing therapies for sexual dysfunction. Dr. Kim received his BA in biology, MA in biochemistry and PhD in physiology from Boston University and completed a research fellowship in cardiology at the University of California, San Diego.


